Menu

Thirdhand Smoke Contamination in a Neonatal Intensive Care Unit (NICU)

Status and phase

Completed
Phase 1

Conditions

Nicotine Exposure

Treatments

Drug: 2% Chlorohexidine Gluconate soap
Drug: 62% ethyl alcohol-based hand sanitizer

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04155697
HSC-MS-15-0614 (sub-study)
R03HD088847 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of the study is to quantify the efficacy of hand washing (HW) and ethyl alcohol-based hand sanitizer (S) for third-hand smoke (THS) removal in a sub-sample of non-staff smokers using nicotine wipes on adjacent fingers before and after HW/S.

The hypotheses are that detectable levels of surface nicotine will remain on participants' fingers, regardless of hand washing (HW) and ethyl alcohol-based hand sanitizer (S) attempts and that greater finger levels of surface nicotine will remain after alcohol sanitization compared to hand washing.

Enrollment

14 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria ():

  • Any non-staff participants visiting the NICU (including friends and family members of the infants' caregivers)
  • Consented to and provided a finger wipe
  • Report being a smoker
  • Smoking status verified by an exhaled carbon monoxide (CO) level of >7 parts per million

Exclusion Criteria:

  • Unwilling to comply with research procedures (i.e., finger wipes)
  • Does not speak English.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

14 participants in 2 patient groups

Hand washing with soap for thirdhand smoke removal
Active Comparator group
Treatment:
Drug: 2% Chlorohexidine Gluconate soap
Ethyl alcohol-based sanitizer for thirdhand smoke removal
Active Comparator group
Treatment:
Drug: 62% ethyl alcohol-based hand sanitizer

Trial contacts and locations

1

There are currently no registered sites for this trial.

Timeline

Last updated: May 09, 2022

Start date

Jun 07, 2017 • 7 years ago

End date

Sep 11, 2018 • 6 years ago

Today

May 03, 2025

Data sourced from clinicaltrials.gov